These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2191313)

  • 1. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
    [No Abstract]   [Full Text] [Related]  

  • 3. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
    Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
    Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic apheresis in the treatment of drug-resistant primary glomerulonephritis].
    Sakai S; Sakai O
    Nihon Rinsho; 1992 Jan; 50 Suppl():139-47. PubMed ID: 1578669
    [No Abstract]   [Full Text] [Related]  

  • 6. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy.
    Yokoyama K; Sakai S; Sigematsu T; Takemoto F; Hara S; Yamada A; Kawaguchi Y; Hosoya T
    Clin Nephrol; 1998 Jul; 50(1):1-7. PubMed ID: 9710340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
    Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
    Muso E; Mune M; Yorioka N; Nishizawa Y; Hirano T; Hattori M; Sugiyama S; Watanabe T; Kimura K; Yokoyama H; Sato H; Saito T
    Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LDL-apheresis for refractory nephrotic syndrome].
    Muso E
    Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of focal segmental glomerulosclerosis(FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis].
    Takaki A; Nakatsuka A; Satou C; Iwata Y; Ikeda H; Fukushima M
    Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):806-12. PubMed ID: 12607970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
    Araki H; Ono S; Nishizawa Y; Deji N; Nakazawa J; Morita Y; Kume S; Chin-Kanasaki M; Isshiki K; Araki S; Arimura T; Maegawa H; Uzu T
    Intern Med; 2015; 54(17):2213-7. PubMed ID: 26328649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on LDL apheresis for nephrotic syndrome.
    Raina R; Krishnappa V
    Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.
    Hattori M; Ito K; Kawaguchi H; Tanaka T; Kubota R; Khono M
    Pediatr Nephrol; 1993 Apr; 7(2):196-8. PubMed ID: 8476719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
    Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
    Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
    Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
    J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
    Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Refractory nephrotic syndrome].
    Saito T
    Nihon Rinsho; 2004 Oct; 62(10):1794-9. PubMed ID: 15500120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone.
    Yokoyama K; Sakai S; Yamaguchi Y; Suzuki Y; Hinoshita F; Hara S; Yamada A; Ogura Y; Kawaguchi Y; Sakai O
    Nephron; 1996; 72(2):318-20. PubMed ID: 8684548
    [No Abstract]   [Full Text] [Related]  

  • 20. Apheresis for Kidney Disease.
    Furuichi K; Wada T
    Contrib Nephrol; 2018; 196():188-193. PubMed ID: 30041226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.